Perrigo Expands Infant Formula Distribution in China With Founder Group
ALLEGAN — Perrigo Co. (Nasdaq: PRGO) Wednesday announced it has entered into a supply agreement with Founder Pharma Co. Ltd., a wholly owned subsidiary of China-based Southwest Synthetic Pharmaceutical Corp. Ltd. Perrigo will supply infant formula manufactured in its U.S. facilities, for sale and distribution by Founder Pharma in China.
Said Perrigo chairman and CEO Joseph C. Papa: “Southwest Synthetic is an exciting partner given its strong reputation and healthcare focus. Perrigo’s high quality products and Southwest Synthetic’s strong brand, marketing, and distribution should be a winning combination in the world’s most robust infant formula market.”
Perrigo develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients. The company is the world’s largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. Perrigo’s primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. More at www.perrigo.com.
Southwest Synthetic is located in Chongqing, China and is the largest manufacturing, R&D, and exporting enterprise of biological and chemical synthetic pharmaceutical products in southwest China. It is also a key enterprise in China’s pharmaceutical industry and is one of China’s pharmaceutical enterprises with the most international approvals. More at www.fsspc.com/en.